mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis

Recent guidelines redefined exercise pulmonary hypertension as a mean pulmonary artery pressure/cardiac output (mPAP/CO) slope >3 mm Hg·L ·min . A peak systolic pulmonary artery pressure >60 mm Hg during exercise has been associated with an increased risk of cardiovascular death, heart failure...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2024-04, Vol.149 (15), p.1172-1182
Hauptverfasser: Hoedemakers, Sarah, Pugliese, Nicola Riccardo, Stassen, Jan, Vanoppen, Arnaud, Claessens, Jade, Gojevic, Tin, Bekhuis, Youri, Falter, Maarten, Moura Ferreira, Sara, Dhont, Sebastiaan, De Biase, Nicolò, Del Punta, Lavinia, Di Fiore, Valerio, De Carlo, Marco, Giannini, Cristina, Colli, Andrea, Dulgheru, Raluca Elena, Geers, Jolien, Yilmaz, Alaaddin, Claessen, Guido, Bertrand, Philippe, Droogmans, Steven, Lancellotti, Patrizio, Cosyns, Bernard, Verbrugge, Frederik H, Herbots, Lieven, Masi, Stefano, Verwerft, Jan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recent guidelines redefined exercise pulmonary hypertension as a mean pulmonary artery pressure/cardiac output (mPAP/CO) slope >3 mm Hg·L ·min . A peak systolic pulmonary artery pressure >60 mm Hg during exercise has been associated with an increased risk of cardiovascular death, heart failure rehospitalization, and aortic valve replacement in aortic valve stenosis. The prognostic value of the mPAP/CO slope in aortic valve stenosis remains unknown. In this prospective cohort study, consecutive patients (n=143; age, 73±11 years) with an aortic valve area ≤1.5 cm underwent cardiopulmonary exercise testing with echocardiography. They were subsequently evaluated for the occurrence of cardiovascular events (ie, cardiovascular death, heart failure hospitalization, new-onset atrial fibrillation, and aortic valve replacement) during a follow-up period of 1 year. Findings were externally validated (validation cohort, n=141). One cardiovascular death, 32 aortic valve replacements, 9 new-onset atrial fibrillation episodes, and 4 heart failure hospitalizations occurred in the derivation cohort, whereas 5 cardiovascular deaths, 32 aortic valve replacements, 1 new-onset atrial fibrillation episode, and 10 heart failure hospitalizations were observed in the validation cohort. Peak aortic velocity (odds ratio [OR] per SD, 1.48; =0.036), indexed left atrial volume (OR per SD, 2.15; =0.001), E/e' at rest (OR per SD, 1.61; =0.012), mPAP/CO slope (OR per SD, 2.01; =0.002), and age-, sex-, and height-based predicted peak exercise oxygen uptake (OR per SD, 0.59; =0.007) were independently associated with cardiovascular events at 1 year, whereas peak systolic pulmonary artery pressure was not (OR per SD, 1.28; =0.219). Peak Vo (percent) and mPAP/CO slope provided incremental prognostic value in addition to indexed left atrial volume and aortic valve area (
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.123.067130